Chapter 54: Adult Cardiovascular Medications

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Imagine you are like the chief engineer of a massive super complex city.

Okay, I'm picturing it.

Right, so you have the central pumping station, hundreds of miles of pressurized pipes, and a really sensitive electrical grid running the whole thing.

Oh, and a very specific vital fluid rushing through those tunnels day and night.

Exactly.

And when something goes wrong in the city, you can't just, you know, throw a wrench at it and hope for the best.

No, definitely not.

You have to know exactly which system is failing, how to fix it without accidentally detonating a neighboring system, and exactly what the collateral damage might be.

That is honestly the perfect way to infrastructure is the cardiovascular system.

Right.

And the tools we use to fix it, the chemical overrides we deploy are some of the most powerful and honestly potentially dangerous medications in modern medicine.

And that is exactly why we are here today.

Welcome to our deep dive.

Today we are custom tailoring our analysis for a very specific listener.

Yes, we are talking directly to you.

You.

You are a nursing student staring down the barrel of the NCLEX and you've handed us a mammoth source.

We are diving into chapter 54 of the Saunders comprehensive review for the NCLEX RN examination, ninth edition.

The big one, cardiovascular medications.

Yep.

But our mission today isn't to read you a dry textbook or rattle off like a boring list of side effects.

We're going to turn you into that chief engineer.

Exactly.

Because the NCLEX doesn't test if you can memorize a flash card.

It tests if you can keep a patient safe.

Right.

It tests clinical reasoning.

So we're going to walk through this material organically looking at the interconnected systems.

We'll start with managing the fluid itself,

the blood and the traffic jams inside the tunnels.

Okay.

The fluid.

Then what?

Then we'll fix the main pump, adjust the pressure in the pipes and finally recalibrate the electrical grid.

I love that blueprint.

Let's jump right into the tunnels.

Let's unpack this.

If the blood is the traffic of our city, what happens when there's a massive pileup?

That's your clot.

Right.

That's our clot.

Now I know when I first looked at this, my instinct was to call anticoagulants blood thinners, but the text is very clear that this is a dangerous oversimplification, right?

It absolutely is.

Yeah.

When you hear anticoagulant, you must remember they do not actually thin the blood.

Wait, really?

They don't.

Not at all.

And they definitely do not dissolve existing clots.

So if there's a pileup of crashed cars on the highway,

anticoagulants aren't the tow trucks.

No, they are the roadblocks.

They prevent the extension of existing clots and stop the formation of new ones by inhibiting the clotting cascade.

Oh, I see.

They just stop more cars from piling into the crash.

Exactly.

And the two heavy hitters you absolutely must master for the exam are heparin and warfarin.

Okay.

Let's unpack the monitoring for these two because the numbers here can feel like total alphabet soup.

It really can.

So with continuous IV heparin, the text says we are watching the APTT, the activated partial thromboplastin time.

The normal unmedicated value is 30 to 40 seconds.

But wait, if I'm giving a patient heparin, I wanted to take longer for their blood to clot.

So I'm not aiming for normal, am I?

Spot on.

You are aiming for therapeutic anticoagulation.

The target for a patient on heparin is 1 .5 to 2 .5 times that normal value.

Okay.

So a bit higher.

Yes.

But if their ABTT shoots up to say 120 seconds, they are in extreme danger of spontaneous bleeding.

Oh, wow.

So if they start bleeding out from their IV sites or their gums, what is my emergency override?

Like what's the antidote?

The antidote for heparin is protamine sulfate.

You must know that.

Protamine sulfate.

Got it.

Okay.

So that's IV heparin for acute situations.

But what about the patient going home?

That's where warfarin comes in, right?

Taken orally.

Correct.

And for warfarin, we monitor entirely different labs, the PT and INR.

Okay.

PT and INR.

The target INR for standard warfarin therapy is 2 to 3.

And just like heparin, if that INR creeps up too high, say past 3 .0 or 4 .0, and the patient is bleeding, you need to intervene.

And the antidote for warfarin is phytonadione, which is just the fancy pharmacological name for vitamin K.

Exactly.

Vitamin K.

Now, I do see the text mention some alternatives so patients don't have to get their blood drawn constantly.

Yes.

Medications like davigar and atexolate work through direct inhibition of thrombin and require no routine blood monitoring.

Oh, that's convenient.

It is.

There are also low molecular weight heparins like inoxiparine and rivaroxaban,

but there is a massive safety tip for inoxiparine.

Why is it?

It is administered as a subcutaneous injection into the abdomen, and it comes in a pre -filled syringe with a tiny air bubble.

Okay.

You never expel that air bubble before injecting.

Wait, why not?

I thought you always pushed the air out.

Normally, yes.

But because that bubble acts as a lock to keep the medication deep in the subcutaneous tissue, preventing it from leaking out and causing massive bruising.

Oh, wow.

That is a brilliant piece of engineering right there.

It really is.

Okay, so anticoagulants set up the roadblock, but what actually clears the crashed cars off the highway?

That brings us to thrombolytics, like alteplase.

These have to be the heavy duty tow trucks.

Or the explosives, depending on how you look at it.

Explosives.

Thrombolytics actually activate plasminogen, which generates plasmin,

and plasmin is an enzyme that aggressively attacks and dissolves the fibrin mesh of the clot.

So it literally blows the clot up.

Basically.

We use them early in a myocardial infarction or an ischemic stroke to restore blood flow.

But logically, if a drug aggressively destroys clots, it's going to destroy the good clots too.

The safety implications must be massive.

They are severe.

You do not give alteplase to someone with active internal bleeding, a history of hemorrhagic stroke, or someone who just had major surgery in the last 10 days.

Because the risk of them bleeding into their brain or abdomen is simply too high?

Exactly.

If they do start hemorrhaging, the specific antidote is aminocaproic acid.

Aminocaproic acid.

Got it.

And to round out our traffic control, we have antiplatelets like aspirin or clopidogrel.

They don't mess with the

clotting cascade like heparin does.

They simply make the individual platelets of the cars less sticky so they bounce off each other instead of clumping.

That's a great way to picture it.

But across all three of these medication types, bleeding is our ultimate safety priority.

We are constantly monitoring for bruising, tarry stools, and GI bleeding.

Exactly.

You are protecting the integrity of the fluid.

All right.

The tunnels are clear.

But what if the central pump is failing?

Let's move to the heart itself.

Before we just throw drugs at a failing heart, we have to understand why it's failing.

Absolutely.

The songers text has a really illuminating section.

Box 54 .5 and figure 54 .1 on the vicious cycle of heart failure.

This is a master class in maladaptive physiology.

When the heart muscle weakens and cardiac output drops, the rest of the body panics because it isn't getting enough oxygenated blood.

So what does it do?

So the it shoots adrenaline into the system, forcing the heart to beat faster.

Wait, hold on.

You're telling me the body's natural response to a weak failing pump is to whip it and make it work faster and harder?

I know it sounds crazy.

It seems like a terrible evolutionary design.

It is terrible for chronic conditions.

And it actually gets worse.

How does it get worse?

Because cardiac output is low.

The kidneys aren't getting enough blood flow.

The kidneys think the body's dehydrated.

So they activate the renin angiotensin aldosterone system or the RAAS.

Okay, the RAAS.

This system ruthlessly retains sodium and water and constricts the blood vessels.

So let me get this straight.

The heart is already exhausted and failing.

And in response, the body clamps down the pipes to incorrect pressure and then floods those pipes with extra retained water.

Yes.

It's forcing a dying pump to push heavier fluid against a tighter space.

Precisely.

The heart dilates, the muscle stretches out like an old rubber band, output drops even further, and the cycle accelerates.

The patient essentially begins to drown in their own fluids.

Wow.

Okay.

So to break that cycle in a severe acute crisis, we use positive inotropic medications like dobutamine and dopamine.

Positive inotropic just means they increase the force of the myocardial contraction.

They turn up the pump's power for a short -term rescue.

But I want to talk about a very specific, very famous drug in this category.

Ah, let me guess.

Here's where it gets really interesting.

Digoxin.

Ah, yes.

The cardiac glycoside.

Digoxin is fascinating because it does two things simultaneously.

It has a positive inotropic effect.

It makes the heart squeeze harder.

Okay.

But it also has a negative chronotropic effect.

It slows the heart rate down.

Harder but slower.

That gives the heart time to actually fill with blood before it gives a massive efficient squeeze.

Exactly.

How does it manage that?

It inhibits the sodium -potassium pump in the cardiac cells.

By blocking that pump, sodium builds up inside the cell, which then causes calcium to build up inside the cell.

And calcium is the ultimate trigger for muscle contraction.

Right.

More calcium means a much stronger squeeze.

But this brings up one of the most notorious NCLE -X traps of all time,

the relationship between digoxin and potassium.

Oh, yes.

The therapeutic range for digoxin is incredibly narrow, 0 .5 to 2 .0 nanograms per milliliter.

And if a patient's potassium drops low, they are in extreme danger of digoxin toxicity.

Yes.

And understanding why is the key to never forgetting it.

Hypokalemia, a potassium level below 3 .5, doesn't happen because digoxin depletes potassium.

Right.

It happens because of other drugs like diuretics.

But digoxin and cellular pump we just talked about.

So if the patient doesn't have enough potassium in their blood, there's no competition.

The digoxin gets all the seats on the bus.

Exactly.

It binds too much.

The effect is magnified, and the patient becomes toxic.

It's a fatal game of musical chairs.

So if I'm a student analyzing an assessment question, how do I spot this toxicity early?

What's the very first sign?

Because I know everyone memorizes the yellow -green halos in the vision.

Forget the halos for early detection.

Wait, really?

Yeah.

Visual disturbances and severe bradycardia are late, dangerous signs.

The text explicitly states that early signs of digoxin toxicity are gastrointestinal.

Like what?

Anorexia, nausea, vomiting, and diarrhea.

If your patient on digoxin suddenly pushes their dinner tray away and says they feel sick to their stomach, your clinical reasoning alarm bells should be ringing.

Oh, wow.

And as a safety priority, you always auscultate the apical pulse for one full minute before administering digoxin.

If it's under 60 beats per minute, you hold the medication and call the provider.

Exactly.

Protect the pump.

Okay.

So we've strengthened the pump.

But going back to that vicious cycle, what if the city's pipes are just holding too much water?

The heart is still going to drown.

We have to drain the system.

Yes, we do.

And that brings us to diuretics.

I know there are a lot of them in boxes 54 .6 through 54 .9.

So how should a student categorize these to keep them straight?

Think of them strictly by how they handle potassium because that dictates your nursing priorities.

First, you have thiazide diuretics like hydrochlorothiazide.

These inhibit sodium reabsorption, taking water with it, but they waste potassium out into the urine.

So you monitor for hypokalemia.

Second, you have loop diuretics like furosemide.

These are the heavy hitters.

They cause massive rapid diuresis and they also waste potassium.

But loop diuretics carry a unique safety alert for IV administration.

What's that?

If you push IV furosemide too fast, you alter the fluid and electrolyte balance in the inner ear so rapidly that it causes ototoxicity.

Meaning?

You can literally cause permanent hearing loss.

You must push it slowly, usually over one to two minutes.

Okay, so both thiazides and loops are practically flushing potassium out of the body.

If I'm the nurse, I'm terrified of hypokalemia leading to digoxin toxicity or lethal arrhythmias.

There has to be a drug that pulls the water but holds onto the potassium, right?

There is.

Your third category is potassium -sparing diuretics like spironolactone.

Ah, okay.

These promote sodium and water excretion but actively retain potassium.

However, you trade one danger for another.

Let me guess.

Hyperkalemia.

Exactly.

The primary concern here isn't hypokalemia.

It's a massive risk of hyperkalemia.

You must teach these patients to avoid potassium -rich foods and salt substitutes.

Wait, why salt substitutes?

Because most commercial salt substitutes are just pure potassium chloride.

If a patient on spironolactone uses them, their potassium levels will skyrocket and stop their heart.

That is terrifying.

Okay, aside from draining the fluid, we can lower the pressure by physically widening the pipes.

Let's talk about medications that affect the nervous system's control of blood vessels.

Alpha and central blockers.

Right.

Peripherally acting alpha blockers like doxazosin cause the vessels to dilate.

But if we rapidly dilate the vessels, we run into a physics problem.

Orthostatic hypotension.

Right.

When a healthy person stands up, the blood vessels in their legs instantly constrict to push blood up to the brain against gravity.

Makes sense.

But if those vessels are chemically blocked from constricting,

the blood pools in the legs, the pressure drops, and the patient passes out.

You have to teach them to change positions very slowly.

And then you have the centrally acting sympatholitics like clonidine.

These work deep in the brain to reduce the sympathetic nervous system's tone.

The absolute golden rule here.

Never stop them abruptly.

Because if you do, the body, which has been fighting the medication by upregulating its receptors, suddenly experiences a massive uninhibited sympathetic surge.

Rebound hypertension so severe, it can cause a stroke.

Spot on.

Now the nervous system isn't the only way the body controls blood pressure.

We also have hormonal control via the kidneys.

Right.

Back to that RAS system we talked about earlier.

To stop the kidneys from clamping down the pipes, we use ACE inhibitors and ARBs.

The ACE inhibitors end in parole, like listen to Bipple.

They literally block the angiotensin -converting enzyme, stopping the creation of angiotensin II, which is a potent vasoconstrictor.

And ARBs.

ARBs end in sartin, like those sartin, and they just block the receptors for angiotensin II.

Both result in vasodilation and lower blood pressure.

But ACE inhibitors have a very specific side effect that the NCLEX absolutely loves.

The persistent dry cough.

I always wondered why that happens.

It comes down to the mechanism.

That angiotensin -converting enzyme also breaks down a peptide called bradykinin.

Okay.

If you inhibit the enzyme, bradykinin builds up in the respiratory tract, irritating the airways and causing that constant nagging cough.

So what do we do?

If your patient develops this, you don't just tell them to buy cough drops.

You notify the primary healthcare provider because they likely need to be switched over to an ARB, which doesn't affect bradykinin.

That makes so much sense.

Now, speaking of vasodilation, let's look at a true clinical emergency.

Angina or severe chest pain.

The heart muscle itself isn't getting enough oxygen because its own pipes, the coronary arteries are constricted.

This is a critical section.

The textbook has a fantastic clinical judgment.

Take action box for nitroglycerin.

Let's walk through it.

This is pure high -stakes nursing application.

Your patient hits the call light reporting crushing, subternal chest pain.

What is your very first move?

First, I assess.

I'm checking the pain characteristics, heart rate, rhythm, and crucially, blood pressure.

Once I know my baseline, I administer one nitroglycerin tablet

sublingually under the tongue.

And you explicitly tell them not to swallow it because it will be destroyed by the liver before it ever reaches the heart.

Right.

So I give the first tablet and I stay with them.

I look at the clock and wait exactly five minutes.

If the pain is not relieved and their blood pressure hasn't tanked, I give a second tablet.

Perfect.

Wait another five minutes.

Still in pain, give a third tablet.

If that third tablet doesn't work after five minutes, I'm immediately contacting the primary health care provider or initiating emergency protocols.

Three doses is the absolute maximum.

And when you are discharging this patient, the safety teachings are vital.

They must sit down when they take it because the rapid vasodilation will cause their blood pressure to drop and they get easily faint and hit their head.

Right.

Safety first.

They also need to check expiration dates.

Expired nitro degrades and will not save their

There is also a fatal drug interaction here.

Yes.

Nitroglycerin is absolutely contraindicated if the patient is taking medications for erectile dysfunction like sildenafil.

Because of the vasodilation.

Exactly.

Both drugs cause massive vasodilation.

Combining them causes a fatal irreversible drop in blood pressure.

Wow.

Okay.

Let's keep expanding our control over the system.

Let's talk about the regulators beta blockers.

These end in olol.

Metoprolol, propranolol.

Yes, the olols.

They block the sympathetic nervous system, decreasing heart rate, decreasing blood pressure, and reducing the overall workload of the heart.

So what does this all mean for a patient with other conditions?

What if my patient on a beta blocker is also a diabetic?

You have just highlighted a massive NCLEX safety alert.

For a diabetic patient experiencing hypoglycemia dangerously low blood

What is their body's early warning system?

They get the shakes, tachycardia, sweating, nervousness.

It's an adrenaline response.

Exactly.

It's the sympathetic nervous system screaming for help.

Yeah.

But a beta blocker blocks that exact system.

Oh, wow.

It masks the early warning signs of hypoglycemia.

The patient won't feel their heart racing and their blood sugar could drop to a coma inducing level without them ever realizing it.

They must monitor their blood glucose meticulously by the clock, not by how they feel.

That is huge.

What if the patient has asthma?

Then you must be hypervigilant about non -selective beta blockers like propranolol.

They don't just block beta 1 receptors in the heart.

They also cross over and block beta 2 receptors in the lungs.

And beta 2 controls the airways.

Yes.

Blocking beta 2 causes the airways to constrict.

In an asthmatic patient, a non -selective beta blocker can trigger a

We also have calcium channel blockers or CCBs like Giltiazem and M.

laudapine.

How are these different?

They physically block calcium from entering the cells of the heart and the smooth muscle of the blood vessels.

Without calcium, the muscle simply cannot contract as forcefully.

It drastically decreases the workload of the heart and promotes vasodilation.

Speaking of ultimate vasodilation, we have to spotlight sodium nitroprusside.

This is an IV medication used for acute hypertensive emergencies.

It acts directly on the smooth muscle to draw pressure fast.

But the safety alerts on this one are out of a sci -fi movie.

They really are.

Sodium nitroprusside rapidly decomposes when exposed to light.

The IV bag must be wrapped in a dark, opaque sleeve provided by the manufacturer.

If the solution turns red, green, or blue, you discard it immediately.

Red, green, or blue, throw it out.

Furthermore, a byproduct of its metabolism is cyanide.

You must continuously monitor the patient for cyanide and thiocyanate toxicity.

That is intense.

And before we move on, there's also nesterotide, right?

Briefly, yes.

Nesterotide is a recombinant human B -type natriuretic peptide.

It's used for decompensated heart failure to promote vasodilation and diuresis.

Awesome.

Let's move to the electrical grid.

Antidisrhythmics are complex, but the chapter categorizes them by what they block.

Class I are sodium channel blockers, Class II are our beta blockers, Class III block potassium channels, and Class IV are the calcium channel blockers.

The major spotlight for the NCLEX in this section falls on amiodarone, a Class III antidisrhythmic.

Okay, what does amiodarone do?

It delays repolarization,

but its specific danger is that it can prolong the QT interval on an EKG.

If that QT interval gets stretched too long, it can throw the patient into a lethal, twisting ventricular rhythm called torsades de pointes.

Continuous cardiac monitoring is non -negotiable.

And if the electrical grid fails completely and the heart stops, we reach for the adrenergic agonists, these are your code blue drugs, epinephrine to stimulate the heart and cardiac arrest, and dopamine or norepinephrine to cause massive vasoconstriction and increase blood pressure in severe shock.

Finally, as the chief engineer, you need to prevent future blockages by clearing the cholesterol gunk off the tunnel walls.

We use antalapemics.

The statins.

Yes, the most famous are the HMG -CoA reductase inhibitors.

They're known as statins.

Atorvastatin, simvastatin.

Two crucial safety teachings you must look out for with statins.

First, unexplained muscular pain or weakness.

This could be rhabdomyolysis.

A life -threatening breakdown of muscle tissue, where the muscle proteins clog and destroy the kidneys.

They must report muscle pain immediately.

Second, statins increase the nicotinic acid, an older antalapemic.

It causes profound cutaneous flushing of the skin.

The patient turns red and feels intensely hot.

Sounds uncomfortable.

It is very uncomfortable, but there's a clinical trick.

Taking an NSAID like ibuprofen 30 minutes prior to the dose can significantly reduce that flushing by inhibiting the prostablandins that cause it.

All right, we've covered the physiology, the plumbing, the pumps, and the electricity.

Let's put this into practice.

Let's shift into pure tutoring mode and look at exactly how a student should think through the review questions at the end of the chapter.

Okay,

this requires clinical math reasoning.

From our traffic tunnel discussion, normal unmedicated APTT is telling me to 40 seconds.

We want therapeutic anticoagulation, which is 1 .5 to 2 .5 times normal.

So taking the baseline of 30 times 2 is 60.

The correct answer is 60 seconds.

Looking at the distractors, 12 .5 seconds is a normal PT time for warfarin, not heparin.

28 seconds means they are subtherapeutic and at risk for a clot, and 120 seconds puts them in dangerous bleeding territory.

Beautifully reasoned.

Now look at question four.

A patient receives IV prokanamide and complains of dizziness.

What intervention do you implement first?

Options obtain a 12 lead EKG, check blood sugar, auscultate apical pulse and blood pressure, or measure the QRS interval.

The test taking strategy here centers on the strategic word first.

Dizziness after an IV cardiac med tells me their brain isn't getting enough oxygen, which means we suspect a sudden drop in cardiac output.

Exactly.

So what do you do?

Do we leave the room to hunt down an EKG machine?

No.

We apply the nursing process, assess the immediate physiological effect first.

We auscultate the apical pulse and check the blood pressure.

Direct assessment of vital signs always beats out gathering secondary equipment when a patient is symptomatic.

That is exactly the mindset you need.

Finally, let's look at question two.

You are giving discharge instructions to a patient taking warfarin.

Which statement by the negative event query needs further teaching?

Is NCLEX code for which of these statements is horribly wrong and dangerous?

Yes.

You aren't looking for the correct medical action.

You are hunting for the mistake.

The correct answer here is the patient saying, I will take coded aspirin for my headaches.

Why is that wrong?

Aspirin is an antiplatelet.

Combining it with warfarin is a massive compounding bleeding risk.

They need further teaching to understand they absolutely

You see how the NCLEX works.

It's not just what does this drug do.

It's how does this drug change my nursing priorities?

Which brings us to our next step.

To preserve the exact logical flow of the Saunders text, what comes immediately after the cardiovascular system.

Unit 13, renal and urinary problems of the adult client.

And that makes perfect physiological sense.

As we just discussed with the REAS system and diuretics, managing fluid volume and blood pressure relies entirely on the kidneys.

Right.

You can't fix the city's plumbing if you don't understand the main filtration plan.

So next, the focus will naturally shift to acute kidney injury, the mechanics of dialysis, and the intense monitoring required after kidney transplants.

So all of this cardiovascular knowledge is foundational for everything that comes next.

Exactly.

When you're sitting in that exam room, don't just see a list of side effects.

See the interconnected system.

When you understand why a loop diuretic drops blood pressure, why that requires the heart to work differently, and why that impacts potassium, the NCLE -X stops being a memory test and starts being a clinical reasoning puzzle that you know how to solve.

Before we go, chew on this.

We've spent this whole time talking about how to manually override the cardiovascular system with mass produced chemicals.

But with the rapid rise of pharmacogenomics, we are approaching an era where we won't just guess which of these drugs will work based on standard dosages.

Oh, that's a fascinating point.

We will literally print a custom chemical profile based on a patient's exact DNA, predicting exactly how their unique enzymes will metabolize a beta blocker or an ACE inhibitor.

Imagine how that is going to change the interconnected system of the NCLE -X in 10 years.

It's going to revolutionize clinical reasoning entirely.

But for today, you have the blueprint you need.

You've got this.

We believe in you.

Thank you for joining us on this deep dive and a warm thank you from all of our partners at the Last Minute Lecture Team.

Next time you look at that intricate, pressurized, city grid of the cardiovascular system, just remember you know how the pipes work.

Keep studying, keep connecting the dots, and we'll see you on the other side.